Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 18 citing articles:

PD-L1 testing by immunohistochemistry in Immuno-Oncology
Semir Vranić, Zoran Gatalica
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 60
Immunotherapy: an emerging modality to checkmate brain metastasis
Aatiya Ahmad, Parvez Κhan, Asad Rehman, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
Alejandro Ríos-Hoyo, Edurne Arriola
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC
Jinsheng Liu, Yuxiang Cai, Yong-Ze He, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities
Dairan Zhou, Zhenyu Gong, Dejun Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer
Anna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Journal of Neuro-Oncology (2023) Vol. 163, Iss. 3, pp. 597-605
Open Access | Times Cited: 11
Outcome differences between PD-1/PD-L1 inhibitors-based monotherapy and combination treatments in NSCLC with brain metastases
Hao‐Wei Wang, Fangfang Liu, Xiaoxia Chen, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target
Hao Duan, Jianlan Ren, Shiyou Wei, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Cytokine Release Syndrome in a Patient With Metastatic Triple-Negative Breast Cancer Treated With Hypofractionated Radiation Therapy, Who Had Previously Undergone Immunotherapy: A Case Report
Jee Suk Chang, Jee Hung Kim
Advances in Radiation Oncology (2024) Vol. 9, Iss. 7, pp. 101513-101513
Open Access | Times Cited: 2
Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma
Jianing Chen, Hainan Yang, Chao Zhao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Metastatic brain tumors: from development to cutting‐edge treatment
Guilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
MedComm (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases
Meichen Li, Jing Chen, Hui Yu, et al.
OncoImmunology (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
PD-(L)1 inhibitors plus bevacizumab and chemotherapy as first-line therapy in PD-L1-negative metastatic lung adenocarcinoma: a real-world data
Yihui Ge, Yujing Zhan, Jie He, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 3
Open Access
The emerging role of immune checkpoint blockade for the treatment of lung cancer brain metastases
Xiancheng Wu, Laura P. Stabile, Timothy F. Burns
Clinical Lung Cancer (2024) Vol. 25, Iss. 6, pp. 483-501
Closed Access
The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature
Eleni Eleftheriadou, Maria Saroglou, Nikolaos Syrigos, et al.
Monaldi Archives for Chest Disease (2024)
Open Access
Integrated Analyses of Multi-omic Data Derived from Paired Primary Lung Cancer and Brain Metastasis Reveals the Metabolic Vulnerability as a Novel Therapeutic Target
Hao Duan, Jianlan Ren, Shiyou Wei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunotherapy for metastatic non–small cell lung cancer: Is it really a no‐brainer?
Lauren K. Young, Balázs Halmos
Cancer (2024) Vol. 130, Iss. 15, pp. 2577-2581
Closed Access
The role of immune checkpoint inhibitors in patients with intracranial metastatic disease
Zeel Patel, Matthew Cho, Sunit Das
Journal of Neuro-Oncology (2023) Vol. 161, Iss. 3, pp. 469-478
Closed Access
Page 1

Scroll to top